HSIC
Henry Schein, Inc. · NASDAQ
- Sector Distribution Services
- Industry Medical Distributors
- Website enryschein.com
- Employees(FY) 24000
- ISIN US8064071025
Performance
-9.36%
1W
-6.71%
1M
-3.75%
3M
+2.26%
6M
-7.78%
YTD
-4.88%
1Y
Profile
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Technical Analysis of HSIC 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-19 07:24
- 2024-12-18 11:09
Is Henry Schein, Inc. (NASDAQ:HSIC) Potentially Undervalued?(Simply Wall St.)
- 2024-12-17 19:00
HSIC: Lowering target price to $77.00(Argus Research)
- 2024-12-17 06:30
- 2024-12-16 17:30
- 2024-12-13 09:40
- 2024-12-12 14:32
- 2024-12-10 19:00
HSIC: Lowering target price to $78.00(Argus Research)
- 2024-12-05 11:30
- 2024-12-04 05:36
- 2024-12-03 19:00
HSIC: Lowering target price to $79.00(Argus Research)
- 2024-11-26 19:00
HSIC: Raising target price to $81.00(Argus Research)
- 2024-11-26 09:40
- 2024-11-22 16:00
- 2024-11-21 08:48
- 2024-11-21 06:30
- 2024-11-21 03:59
Henry Schein to acquire medical supplier Acentus(MedTech Dive)
- 2024-11-20 17:30
- 2024-11-20 06:51
- 2024-11-20 06:30
- 2024-11-19 17:30
- 2024-11-18 17:10
- 2024-11-18 16:51
- 2024-11-18 16:00
- 2024-11-18 15:35
Sector Update: Health Care(MT Newswires)
- 2024-11-18 14:50
- 2024-11-18 13:35
- 2024-11-18 03:51
- 2024-11-16 10:12
- 2024-11-13 05:23
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.